SC
AGN

Sculptor Capital’s Allergan plc AGN Stock Holding History

Sculptor Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-234,328
Closed -$41.5M – 339
2020
Q1 		$41.5M Buy
+234,328
New +$44.1M 0.59% 31
2019
Q3 		– Sell
-901,143
Closed -$151M – 339
2019
Q2 		$151M Buy
+901,143
New +$125M 0.8% 28
2017
Q3 		– Sell
-3,082
Closed -$717K – 432
2017
Q2 		$749K Buy
+3,082
New +$724K ﹤0.01% 261
2017
Q1 		– Sell
-24,470
Closed -$5.7M – 436
2016
Q4 		$5.14M Sell
24,470
-550,530
-96% -$114M 0.04% 194
2016
Q3 		$132M Buy
+575,000
New +$141M 0.76% 39
2016
Q1 		– Sell
-582,516
Closed -$167M – 468
2015
Q4 		$182M Sell
582,516
-3,453,950
-86% -$1.03B 0.99% 30
2015
Q3 		$1.1B Buy
4,036,466
+360,704
+10% +$111M 3.82% 1
2015
Q2 		$1.12B Buy
3,675,762
+13,838
+0.4% +$4.13M 3.23% 2
2015
Q1 		$1.09B Buy
3,661,924
+320,352
+10% +$91.3M 3.53% 1
2014
Q4 		$860M Sell
3,341,572
-1,491,239
-31% -$373M 2.32% 2
2014
Q3 		$1.17B Buy
4,832,811
+1,652,109
+52% +$370M 3.37% 1
2014
Q2 		$709M Buy
3,180,702
+545,735
+21% +$113M 2.12% 1
2014
Q1 		$542M Sell
2,634,967
-16,482
-0.6% -$3.26M 1.79% 4
2013
Q4 		$445M Buy
2,651,449
+1,562,250
+143% +$244M 1.14% 11
2013
Q3 		$157M Buy
1,089,199
+96,467
+10% +$12.9M 0.45% 58
2013
Q2 		$125M Buy
+992,732
New +$112M 0.39% 66

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Sculptor Capital's AGN Position: Q2 2020 in Review

Sculptor Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 234,328 shares — an estimated $41.5M sold.

Sculptor Capital first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $1.17B in Q3 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sculptor Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Sculptor Capital sold 234,328 Allergan plc shares in Q2 2020, an estimated $41.5M.
  • Sculptor Capital first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • Sculptor Capital's Allergan plc position peaked at $1.17B in Q3 2014.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sculptor Capital's 13F filing for Q2 2020, filed 14 Aug 2020.